Hannah Nicole Chaudhury

Dr. Hannah Nicole Chaudhury

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Asad UllahAsad Ullah
Asad Ullah
AYAbdul Qahar Khan Yasinzai
Abdul Qahar Khan Yasinzai
KLKue Tylor Lee
Kue Tylor Lee
TCTristin Chaudhury
Tristin Chaudhury
HCHannah Nicole Chaudhury
Hannah Nicole Chaudhury
Nabin R KarkiNabin R Karki
Nabin R Karki
Background: This retrospective study aims to examine the patient demographics, survival rates, and treatment methods for small-cell neuroendocrine carcinoma (SCNEC) and large-cell neuroendocrine carcinoma (LCNEC) of prostate origin while also identifying the main differences between common types of prostate cancer with comparative analysis for survival. Methods: Our analysis utilized the Surveillance, Epidemiology, and End Results database (SEER), and data was collected from 2000–2020. Cox proportional hazards and chi-squared analysis were used for statistical analysis. Results: A total of 718 cases of prostate small and large neuroendocrine carcinoma were identified. The median age was 71.5 years, and the median follow-up was 11.0 years (95% confidence interval (95% CI) = 9.2–12.8). Most patients were over the age of 80 years (33.8%) and Caucasian (74.4%). The overall 5-year survival was 8.0% (95% CI = 6.8–9.2). The 5-year OS for Caucasians was 7.3% (95% C.I. 6.0–8.3). For Black Americans, the 5-year OS was 11.9% (95% C.I. 7.3–16.5). For Hispanics, the 5-year OS was 12.2% (95% C.I. 7.7–16.7). The 5-year cause-specific survival (CSS) was 16.2% (95% CI = 14.3–18.1). For treatment modality, the five-year survival for each were as follows: chemotherapy, 3.5% (95% CI = 2.1–4.9); surgery, 18.2% (95% CI = 13.6–22.8); multimodality therapy (surgery and chemotherapy), 4.8% (95% CI = 1.7–7.9); and combination (chemoradiation with surgery), 5.0% (95% CI = 1.0–9.0). The prognostic nomogram created to predict patient survivability matched the findings from the statistical analysis with a statistical difference found in race, income, housing, stage, and nodal status. The nomogram also indicated a slight increase in mortality with tumors of greater size. This analysis showed a slight increase in mortality for patients of Asian race. In addition, there was a significant increase in death for patients with stage 3 tumors, as well as patients who underwent surgery and radiation. Furthermore, we performed propensity score matching for survival differences, and no survival difference was found between SCNEC and LCNEC. Conclusions: Asian patients, larger tumor size, and distant disease were associated with worse long-term clinical outcomes. By leveraging insights from registry-based studies, clinicians can better strategize treatment options, improving patient outcomes in this challenging oncology arena.

28 April 2025 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
AUAsad Ullah
Asad Ullah
AYAbdul Qahar Khan Yasinzai
Abdul Qahar Khan Yasinzai
HCHannah Nicole Chaudhury
Hannah Nicole Chaudhury
ACAbdullah Chandasir
Abdullah Chandasir
TNTena Nguyen
Tena Nguyen
ASAmir Humza Sohail
Amir Humza Sohail
Leiomyosarcoma of the skin is a rare malignant mesenchymal neoplasm categorized as cutaneous or subcutaneous. This study identified demographic and pathological factors affecting the prognosis and treatment of leiomyosarcoma of the skin. Data of patients with skin leiomyosarcoma was extracted from 2000 to 2020 using the Surveillance, Epidemiology, and End Results database. Propensity score matching and prognostic nomograms were used to analyze survival rate predictions. Most patients were >65 years of age (50.5%), male (78.8%), and White (88.5%). The overall 5-year survival was 79.9% (95% confidence interval [CI] = 77.4–82.6), and the 5-year cause-specific survival rate was 95.7% (95% CI = 94.2–97.2). Based on treatment, the 5-year cause-specific survival rate was 82.9% (95% CI = 80.3–85.6) for surgery only, 60.2% (95% CI = 47.7–76.0) for both radiation and surgery, and 68.2% (95% CI = 58.9–78.9) for no treatment. Multivariable analysis showed that head and neck tumors were associated with worse mortality. The results provide valuable insights that could shape development of future clinical protocols for skin leiomyosarcoma and impact patient care and treatment efficacy.

12 January 2026 in International Journal of Women's Dermatology
Verified
Journal Article
Open access
HCHannah Nicole Chaudhury
Hannah Nicole Chaudhury
NRNicole Remmert
Nicole Remmert
HCHelen Chen
Helen Chen
MTMichelle Tarbox
Michelle Tarbox
Background: Striae distensae (SD) (stretch marks) are common dermal scars resulting from rapid skin stretching during puberty, pregnancy, or weight changes and disproportionately affect women. Management remains challenging, particularly in individuals with darker skin tones, due to variable efficacy and the risk of postinflammatory hyperpigmentation with certain therapies. Objective: To review current and emerging treatment modalities for SD across all Fitzpatrick skin types, with an emphasis on efficacy, safety, and the role of combination therapies. Methods: A comprehensive literature review was conducted using peer-reviewed clinical trials, observational studies, and dermatologic reviews evaluating topical, procedural, laser-based, and combination therapies for SD. Treatments were analyzed based on mechanism of action, clinical outcomes, skin type suitability, and reported adverse effects. Results: Topical tretinoin demonstrated modest efficacy dependent on concentration and treatment duration. Laser-based therapies, including ablative and nonablative fractional lasers, improved collagen remodeling and stretch mark appearance, with nonablative lasers showing better tolerability in darker skin types. Microneedling and fractional microneedling radiofrequency were effective and cost-efficient options across skin types. Combination therapies, particularly those integrating microneedling, radiofrequency, platelet-rich plasma, or fractional CO 2 lasers, yielded superior outcomes compared with monotherapy, especially for striae alba. Striae rubra generally responded more favorably than striae alba across treatment modalities. Limitations: Heterogeneity among studies, including inconsistent outcome measures, variable treatment protocols, and limited long-term follow-up, restricts direct comparison of therapeutic efficacy. Additionally, many studies included small sample sizes and lacked standardized assessment tools such as a uniform visual analog scale and Dermatology Life Quality Index scoring. Conclusion: Multiple therapeutic options exist for the management of SD, with treatment selection influenced by striae stage and Fitzpatrick skin type. Combination therapies demonstrate the most promising results, particularly for treatment-resistant striae alba and patients with darker skin tones. Standardization of outcome measures and further high-quality comparative studies are needed to optimize individualized treatment strategies.

18 April 2025 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
HCHannah Nicole Chaudhury
Hannah Nicole Chaudhury
NRNicole Remmert
Nicole Remmert
MPMeredith Pham
Meredith Pham
MTMichelle Tarbox
Michelle Tarbox
Lichen planus pemphigoides (LPP) is an uncommon autoimmune dermatosis characterized by a combination of lichenoid lesions and bullous lesions. While its pathogenesis is often considered idiopathic, some cases have been associated with certain medications and infections. The standard treatment for LPP involves systemic corticosteroids. However, the suboptimal recurrence rate of 20% and the presence of various side effects highlight the need for alternative approaches. Recognizing the role of proinflammatory cytokines in the pathogenesis of LPP and targeting their reduction and related pathways has emerged as a promising therapeutic strategy. This case report details the experience of a 67-year-old woman with a history of LPP, showing disease progression despite undergoing multiple conventional therapies. Faced with the inadequacy of traditional treatments, we achieved successful results by using apremilast as an effective intervention.

28 April 2025 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
HCHannah Nicole Chaudhury
Hannah Nicole Chaudhury
NHNicholas Hancock
Nicholas Hancock
JVJorge Rodriguez Vazquez
Jorge Rodriguez Vazquez
DADauod Arif
Dauod Arif
GLGenevieve Lapointe
Genevieve Lapointe
AOAndré M. Oliveira
André M. Oliveira
Spindle cell rhabdomyosarcoma, a rare subtype of adult soft tissue tumor, is characterized by specific histological and clinical features. This report presents a case of a 21-year-old woman with an intraosseous spindle cell rhabdomyosarcoma in the left frontal region, a less common location in adults. The rarity and atypical presentation of spindle cell rhabdomyosarcoma in adults highlight the importance of thorough histopathological examination and immunohistochemistry in diagnosis. This case emphasizes the complexity of managing such tumors, showcasing the combination of surgical and chemotherapeutic interventions.

8 May 2025 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
KVKritin K. Verma
Kritin K. Verma
HCHelen Chen
Helen Chen
HCHannah Nicole Chaudhury
Hannah Nicole Chaudhury
DRDenise C. Robson
Denise C. Robson
MTMichelle B. Tarbox
Michelle B. Tarbox